The PIM Kinase Inhibitor K00135 Sensitizes Primary Acute Lymphoblas tic Leukaemia (ALL) Cells to DNA Damaging Agents

The PIM Kinase Inhibitor K00135 Sensitizes Primary Acute Lymphoblas tic Leukaemia (ALL) Cells to DNA Damaging Agents

Show other versions (1)

Bibliographic Details
Main Authors:	Da Costa, D, Weston, V, Knapp, S, Taylor, A, Kearns, P, Stankovic, T
Format:	Conference item
Published:	2010

Similar Items

The PIM Kinase Inhibitor K00135 Sensitizes Primary Acute Lymphoblastic Leukaemia (ALL) Cells to DNA-Damaging Agents
by: Da Costa, D, et al.
Published: (2010)

Crystal structure of the PIM2 kinase in complex with an organoruthenium inhibitor.
by: Bullock, A, et al.
Published: (2009)

Thiazolidine derivatives as potent and selective inhibitors of the PIM kinase family.
by: Bataille, C, et al.
Published: (2017)

Synthesis, kinase inhibitory potencies, and in vitro antiproliferative evaluation of new Pim kinase inhibitors.
by: Akué-Gédu, R, et al.
Published: (2009)

Selective bisubstrate inhibitors with sub-nanomolar affinity for protein kinase Pim-1.
by: Ekambaram, R, et al.
Published: (2013)

Structure and substrate specificity of the Pim-1 kinase
by: Bullock, A, et al.
Published: (2005)

Structure and substrate specificity of the Pim-1 kinase.
by: Bullock, A, et al.
Published: (2005)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
by: López-Ramos, M, et al.
Published: (2010)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
by: López-Ramos, M, et al.
Published: (2010)

Inhibition of BRD4 Bromodomains Is a Potent Novel Strategy to Target Apoptosis Resistance in Paediatric ALL
by: Da Costa, D, et al.
Published: (2011)

Crystal structure-guided design of bisubstrate inhibitors and photoluminiscent probes for protein kinases of the PIM family
by: Nonga, OE, et al.
Published: (2021)

Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity.
by: Pogacic, V, et al.
Published: (2007)

Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase.
by: Bullock, A, et al.
Published: (2005)

Ruthenium half-sandwich complexes bound to protein kinase Pim-1
by: Debreczeni, J, et al.
Published: (2006)

Ruthenium half-sandwich complexes bound to protein kinase Pim-1.
by: Debreczeni, J, et al.
Published: (2006)

Electrostatically Enhanced Association of a Pim Kinase Substrate Revealed by Stochastic Detection
by: Harrington, L, et al.
Published: (2014)

PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers.
by: Brault, L, et al.
Published: (2010)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights (September, pg 3175, 2010)
by: Lopez-Ramos, M, et al.
Published: (2011)

BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia.
by: Da Costa, D, et al.
Published: (2013)

Stochastic detection of Pim protein kinases reveals electrostatically enhanced association of a peptide substrate.
by: Harrington, L, et al.
Published: (2013)

PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma.
by: Brault, L, et al.
Published: (2012)

PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma
by: Brault, L, et al.
Published: (2012)

STUDYING THE ROLE OF PIM KINASES IN FLT3-ITD-INDUCED LEUKEMIA REVEALED PIM1 AS REGULATOR OF CXCL12/CXCR4-MEDIATED HOMING AND MIGRATION
by: Brault, L, et al.
Published: (2009)

Effect of single amino acid substitution observed in cancer on Pim-1 kinase thermodynamic stability and structure
by: Lori, C, et al.
Published: (2013)

Dissection of PIM serine/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migration.
by: Grundler, R, et al.
Published: (2009)

Dissecting Proto-Oncogenic PIM Serine/Threonine Kinases in FLT3-ITD-Induced Leukemogenesis: PIM1 Regulates CXCL12/CXCR4-Mediated Homing and Migration
by: Gasser, C, et al.
Published: (2008)

New potent dual inhibitors of CK2 and Pim kinases: Discovery and structural insights (The FASEB Journal (2010) (3175) DOI: 10.1096/fj.09-143743)
by: López-Ramos, M, et al.
Published: (2011)

Recently targeted kinases and their inhibitors-the path to clinical trials.
by: Knapp, S, et al.
Published: (2014)

Recently targeted kinases and their inhibitors - the path to clinical trials
by: Knapp, S, et al.
Published: (2014)

Kinase inhibitor selectivity profiling using differential scanning fluorimetry.
by: Fedorov, O, et al.
Published: (2012)

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
by: Fedorov, O, et al.
Published: (2007)

Insights for the development of specific kinase inhibitors by targeted structural genomics.
by: Fedorov, O, et al.
Published: (2007)

PIM : Perpustakaan Inti Masyarakat
by: Perpustakaan UGM, i-lib
Published: (2003)

Accelerated evolution of PAK3- and PIM1-like kinase gene families in the zebra finch, Taeniopygia guttata.
by: Kong, L, et al.
Published: (2010)

TIC pencetus kejayaan AIP
by: Arifin, Muhidn
Published: (2019)

Quantum tic tac toe.
by: Leaw, Jia Ning.
Published: (2010)

Versatile selective kinase inhibitors: Chemistry and biology of indirubins
by: Gaboriaud-Kolar, N, et al.
Published: (2012)

Product information and management systems (PIMS)
by: Nagesh, K. N.
Published: (2008)

Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.
by: Ciceri, P, et al.
Published: (2014)

Transformable instant community shelter (TICS)
by: Kozlowski, Marek, et al.
Published: (2016)